SCHEMBL22947430

SCHEMBL22947430

c1ccc(-c2nc(-c3ccc(-c4cccc5c4-c4ccccc4S5(c4ccccc4)c4ccccc4)cc3)nc(-c3cccnc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
MAPT P10636 6/20 0.43
TSHR P16473 4/20 0.43
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 7/20 0.39
KDM4E B2RXH2 5/20 0.39
HPGD P15428 5/20 0.39
TP53 P04637 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
MEN1 O00255 1/20 0.39
GLA P06280 1/20 0.39
LMNA P02545 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949646 0.94 ALDH1A1 (0.41) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22947433 0.92 ALDH1A1 (0.40) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22947525 0.90 ADORA3 (0.39) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22947650 0.89 SMN1; SMN2 (0.42) ALDH1A1MAPTTSHRSMN1; SMN2KDM4E
SCHEMBL22947671 0.88 ADORA3 (0.38) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22947637 0.83 ADORA3 (0.38) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22949634 0.83 ADORA3 (0.38) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22947384 0.83 ADORA2A (0.40) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22947375 0.82 SMN1; SMN2 (0.40) ALDH1A1MAPTTSHRPOLBSMN1; SMN2
SCHEMBL22948448 0.82 TSHR (0.37) ALDH1A1MAPTTSHRPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 ALDH1A1 752/4885MAPT 3103/4885TSHR 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.